CYP2E1 Rsa ?/Pst ? polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects.

ABSTRACT: Many studies have examined the association between the CYP2E1 Rsa ?/Pst ? (rs3813867) polymorphism gene polymorphisms and lung cancer risk in various populations, but their results have been inconsistent. The PubMed and CNKI database was searched for case-control studies published up to October 2013. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. In this meta-analysis, we assessed 23 published studies involving comprising 4727 lung cancer cases and 6220 controls of the association between CYP2E1 Rsa ?/Pst ? polymorphism and lung cancer risk. For the homozygote c2/c2 and c2 allele carriers (c1/c2 + c2/c2), the pooled ORs for all studies were 0.73(95% CI = 0.62-0.84; P = 0.005 for heterogeneity) and 0.84 (95% CI = 0.77-0.92; P = 0.001 for heterogeneity) when compared with the homozygous wild-type genotype (c1/c1). In the stratified analysis by ethnicity, the same significantly risks were found among Asians and mixed population for both the c2 allele carriers and homozygote c2/c2. However, no significant associations were found in Caucasian population all genetic models. This updated meta-analysis suggests that CYP2E1 Rsa ?/Pst ? c2 allele is a decreased risk factor for the developing lung cancer among Asians and mixed population.

SUBMITTER: Shen ZT 

PROVIDER: S-EPMC4568918 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature